Ripazepam
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
1-ethyl-3-methyl-8-phenyl-4,6-dihydropyrazolo[4,3-e][1,4]diazepin-5-one
|
|
| Identifiers | |
| CAS Number | 26308-28-1  |
| PubChem | CID 33474 |
| ChemSpider | 30896  |
| UNII | 92000WH9C9 |
| KEGG | C19518 |
| ChEMBL | CHEMBL159298 |
| Chemical data | |
| Formula | C15H16N4O |
| Molar mass | 268.314 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (what is this?) (verify) |
|
Ripazepam is a pyrazolodiazepinone derivative structurally related to certain benzodiazepine drugs, especially zolazepam. It has anxiolytic effects.[1][2]
See also[edit]
References[edit]
- ^ Fitzgerald JE, de la Iglesia FA, McGuire EJ. Carcinogenicity studies in rodents and ripazepam, a minor tranquilizing agent. Fundamental and Applied Toxicology. 1984 Apr;4(2 Pt 1):178-90. PMID 6724192
- ^ Baraldi PG, Manfredini S, Periotto V, Simoni D, Guarneri M, Borea PA. Synthesis and interaction of 5-(substituted-phenyl)- 3-methyl- 6,7-dihydropyrazolo [4,3-e] [1,4]diazepin- 8(7H)-ones with benzodiazepine receptors in rat cerebral cortex. Journal of Medicinal Chemistry. 1985 May;28(5):683-5. PMID 2985787
 |
This sedative-related article is a stub. You can help Wikipedia by expanding it. |
